Pharnext (PAR: ALPHA)

Last close As at 20/01/2025

EUR0.10

0.03 (42.86%)

Market capitalisation

1m

Edison Investment Research is terminating coverage on Pharnext (ALPHA). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

Healthcare | Flash note

Pharnext — Potential licensing deals could add confidence

Healthcare | Update

Pharnext — Improving FY23 financial footing

Healthcare | Flash note

Pharnext — Neovacs trust to manage Pharnext deal

Flash note

Healthcare

Pharnext — PREMIER trial completes patient recruitment

Update

Healthcare

Pharnext — Convertible debt terms revised

Update

Healthcare

Pharnext — Clinically healthy

Update

Healthcare

Pharnext — Back in the saddle again

Update

Healthcare

Pharnext — Pivotal Phase III initiated

Update

Healthcare

Pharnext — R&D day highlights

edison tv

Healthcare

Pharnext – executive interview

Initiation

Healthcare

Pharnext — New efficacy and new indications from old drugs